[1] Understanding the Essentials of Blood Lipid Metabolism. Prog Cardiovasc Nurs 18(1):13-18, 2003. © 2003 Le Jacq Communications, Inc
 
[2] National Ambulatory Medical Care Survey: 2002 Summary http://www.cdc.gov/nchs/data/ad/ad346.pdf
 
[3] CDC's National Center for Health Statistics as published by the American Heart Association, Heart and Stroke Statistics — 2003 Update. Dallas, TX: AHA, 2002
 
[4] Prasad K, Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 1997 Jul 11;132(1):69-76.
 
[5] Bierenbaum ML, Reichstein R, Walkins T. Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation: a preliminary report. J Am Coll Nutr 1993;12:501–4
 
[6] Murray, Michael T, Encyclopedia of Nutritional Supplements: Understanding fats and oils, Pg 237-248 © Prima Publishing 1996
 
[7] Cobias L, et al., Lipid, lipoprotein, and hemostatic effects of fish vs fish oil w-3 fatty acids in mildly hperlidemic males. Am J Clin Nutr 53, 1210- 1216, 1991
 
[8] Murray, Michael T, Encyclopedia of Nutritional Supplements: Vitamins, Pg 49 © Prima Publishing 1996
 
[9] Hodis HN, et al., Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273 1849-1854, 1995
 
[10] Kerckhoffs DA, Hornstra G, Mensink RP. Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr 2003;78:221-7.
 
[11]   Anderson JW, Allgood LD, Lawrence A, et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 2000;71:472-9.
 
[12] Bell LP, Hectorne K, Reynolds H, et al. Cholesterol-lowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA 1989;261:3419-23.
 
[13] DiPalma JR and Thayer WS, Use of Niacin as a drug. Annu Rev Nutr 11, 169-187, 1991
 
[14]   Anon. Inositol hexaniacinate. Altern Med Rev 1998;3:222-3.
 
[15] Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther 1994;8:659-64.
 
[16] Panda S, Kar A. Gugulu (Commiphora mukul) induces triiodothyronine production: possible involvement of lipid peroxidation. Life Sci 1999;65:PL137-41.

[17] Nancy L. Urizar and ­David D. Moore, GUGULIPID: A Natural Cholesterol-Lowering Agent. Annual Review of NutritionVol. 23: 303-313

[18] Szapary PO, Wolfe ML, Bloedon LT, Cucchiara AJ, DerMarderosian AH, Cirigliano MD, Rader DJ. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA. 2003 Aug 13;290(6):765-72.
 
[19] Warshafsky S, Kramer RS, Sivak SL. Effect of garlic on total serum cholesterol: a meta-analysis. Ann Intern Med 1993;119:599–605.

[20] Kleijnen J, Knipschild P, ter Riet GT. Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Br J Clin Pharmacol 1989;28;535–44

[21] ibid
 
[22] Robbers JE, Tyler VE. Tyler's Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: The Haworth Herbal Press, 1999.
 
[23] Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL, Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999 Feb;69(2):231-6.